The role of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in monitoring the immunosuppressive therapy response of inflammatory myofibroblastic tumor

Molecular Imaging and Biology

Volumn 6, Issue 3, 2004, Pages 126-130

  Obrzut, Sebastian L ^a   Halpern, Benjamin S ^a   Monchamp, Travis ^a   Grabski, Karsten ^a   Watts, William J ^a   Czernin, Johannes ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

FDG; Immunosuppressive therapy; Inflammatory myofibroblastic tumor; PET CT

Indexed keywords

CYCLOSPORIN; DEXAMETHASONE; FLUORODEOXYGLUCOSE F 18; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; THALIDOMIDE;

ADULT; ANGINA PECTORIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DRUG RESPONSE; DYSPNEA; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; PLASMA CELL GRANULOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR BIOPSY; TUMOR VOLUME; WEIGHT REDUCTION;

FEMALE; FLUORODEOXYGLUCOSE F18; GRANULOMA, PLASMA CELL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MEDIASTINAL NEOPLASMS; MEDIASTINUM; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 2942648232     PISSN: 15361632     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mibio.2004.03.003     Document Type: Article

References (13)

1. Antoch G. Vogt F.M. Freudenberg L.S. et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology JAMA 290 2003 3199-3206
2. Lardinois D. Weder W. Hany T.F. et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N. Engl. J. Med 348 2003 2500-2507
3. Bakheet S.M. Powe J. Benign causes of 18-FDG uptake on whole body imaging Semin. Nucl. Med 28 1998 352-358
4. Beyer T. Townsend D.W. Brun T. et al. A combined PET/CT scanner for clinical oncology J. Nucl. Med 41 2000 1369-1379
5. Dishop M.K. Warner B.W. Dehner L.P. et al. Successful treatment of inflammatory myofibroblastic tumor with malignant transformation by surgical resection and chemotherapy J. Pediatr. Hematol. Oncol 25 2003 153-158
6. Hagenstad C.T. Kilpatrick S.E. Pettenati M.J. et al. Inflammatory myofibroblastic tumor with bone marrow involvement. A case report and review of the literature Arch. Pathol. Lab. Med 127 2003 865-867
7. Kubota R. Yamada S. Kubota K. et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography J. Nucl. Med 33 1992 1972-1980
8. Yamada S. Kubota K. Kubota R. et al. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue J. Nucl. Med 36 1995 1301-1306
9. Slosman D.O. Spiliopoulos A. Keller A. et al. Quantitative metabolic PET imaging of a plasma cell granuloma J. Thorac. Imaging 9 1994 116-119
10. Imran M.B. Kubota K. Yoshioka S. et al. Sclerosing mediastinitis: findings on fluorine-18 fluorodeoxyglucose positron emission tomography Clin. Nucl. Med 24 1999 305-308
11. Agrons G.A. Rosado-de-Christenson M.L. Kirejczyk W.M. et al. Pulmonary inflammatory pseudotumor: radiologic features Radiology 206 1998 511-518
12. Crespo C. Navarro M. Gonzalez I. et al. Intracranial and mediastinal inflammatory myofibroblastic tumour Pediatr. Radiol 31 2001 600-602
13. Cohade C. Osman M. Pannu H.K. et al. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT J. Nucl. Med 44 2003 170-176